NZ204509A - 2-thiophene acetic acid derivates and their preparation - Google Patents
2-thiophene acetic acid derivates and their preparationInfo
- Publication number
- NZ204509A NZ204509A NZ204509A NZ20450983A NZ204509A NZ 204509 A NZ204509 A NZ 204509A NZ 204509 A NZ204509 A NZ 204509A NZ 20450983 A NZ20450983 A NZ 20450983A NZ 204509 A NZ204509 A NZ 204509A
- Authority
- NZ
- New Zealand
- Prior art keywords
- formula
- process according
- malonate
- ethyl
- alkylmalonate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Description
<div class="application article clearfix" id="description">
<p class="printTableText" lang="en">New Zealand Paient Spedficaiion for Paient Number £04509 <br><br>
204509 <br><br>
Priority Date(s): 3..7^5, <br><br>
Complete Specification Filed: <br><br>
Class: 7. .• .?&......... <br><br>
Publication Date: . F£B. 1986.... P.O. Journal, No: ........ <br><br>
HO DRAWINGS <br><br>
"9 JUNJ983 <br><br>
Patents Form No. 5 <br><br>
NEW ZEALAND PATENTS ACT 1953 <br><br>
COMPLETE SPECIFICATION <br><br>
"PREPARATION OF THIOPHENE COMPOUNDS" <br><br>
-I-,WE ROUSSEL-UCLAF, a French-body corporate of 35 Boulevard des Invalides, Paris 7eme, France, <br><br>
hereby declare the invention, for which-f/we pray that a patent may be granted to -me-Ais, and the method by which it is to be performed, to be particularly described in and by the following statement <br><br>
-1~ (followed by page I A.) <br><br>
- lft- <br><br>
204509 <br><br>
This invention relates to the preparation of <br><br>
2-thiophene acetic acid compounds of formula (I): <br><br>
(I) <br><br>
R <br><br>
in which R represents an alkyl radical of 1 to 4 carbon atoms and R-^, R2 and R^ are the same or different and 5 each represents a hydrogen atom, an alkyl radical cf 1 to 4 carbon atoms or a halogen atom. <br><br>
These compounds are intermediates which can be used in the preparation of pharmaceutical products, in particular anti-inflammatory products. End products 10 which can be prepared from the compounds are described in particular in British Patent Specification No: 1331505. <br><br>
Several processes for the preparation of the compounds are already known. <br><br>
The following process is described in M. 3ERCCT-15 VATTERONI et al., Bull. Soc. Chim. France 1961 p 1920: <br><br>
"s?.s.v i-i t <br><br>
- 2 - <br><br>
20450 3 <br><br>
Q J <br><br>
NaCN <br><br>
O- <br><br>
C^CN <br><br>
co3st2 <br><br>
" OF - <br><br>
Rf "■ r' = alkyl ^2- <br><br>
The following process is described in F. CLEMENCE et al.t Eur J. Med. Chem. 1974 (9) 390: <br><br>
O <br><br>
C0,Et U >-C-C0,K <br><br>
II 2 ^S^ll a <br><br>
0 0 <br><br>
CH^Mgl <br><br>
Q- <br><br>
■ CHCO-H <br><br>
| 2 <br><br>
CH, <br><br>
Ac OH SnCl <br><br>
CH- <br><br>
2QUC-C02H <br><br>
OH <br><br>
The following process is described in United States Patent Specification No: 4219659 and its corresponding British 5 Patent Specification No: 1584120: <br><br>
- 3 - <br><br>
2 04509 <br><br>
halcgenaticn <br><br>
C-CH- <br><br>
-CHflaX <br><br>
= H or a lower alkyl Hal= halogen <br><br>
, » H , hydrocarbon radical or halogen alkali metal hydroxide l1w7-T ^ <br><br>
yT\ i - <br><br>
■C-CCpH <br><br>
i <br><br>
H <br><br>
These processes involve at least 4 stages starting from thiophene or in the case of the last mentioned process an optionally substituted thiophene of formula <br><br>
,/ <br><br>
A new process for the preparation of the compounds has now been discovered. Accordingly, the invention provides a process for the preparation of a 2-thiophene acetic acid compound of formula (I): <br><br>
h-cc2h <br><br>
(I) <br><br>
in which <br><br>
R represents an alkyl radical of 1 to 4 carbon <br><br>
- 4 - <br><br>
204509 <br><br>
atoms; and f?2 and R3 are the same or different and each represents a hydrogen atom, an alkyl radical of 1 to 4 carbon atoms or a halogen atom; <br><br>
5 which process comprises decarbalkoxylating an alkylmalonate of formula (IV): <br><br>
(IV) <br><br>
C02Alk1 <br><br>
C02AIk2 <br><br>
in which R, R^, R2 and R^ are as defined above and Alk^ and Alk2 are the same or different and each represents ■ an alkyl radical of 1 to 4 carbon atoms. <br><br>
10 The new process is better because it produces the compounds more readily. If one starts from chemicals which are available in large quantities at economical prices, the present process produces the compounds in fewer stages. <br><br>
15 The alkylmalonate of formula (IV) is preferably prepared by alkylating in the presence of a strong base a malonate of formula (III): <br><br>
- 5 - <br><br>
204509 <br><br>
ca2Alkl (III) <br><br>
| ^CO, Alk H <br><br>
in which R^, R2» Rg. Alk^ and Alk2 are as defined above, <br><br>
The malonate of formula (III) is preferably prepared by reacting sin alkyl carbonate of formula <br><br>
(Alk1)2C03 <br><br>
in which Alk^ is as defined above, in the presence of a strong base with an ester of formula (II): <br><br>
in which R^, R2» R3 and Alk2 are as defined above. <br><br>
The ester of formula (II) is an ester of v ^ T <br><br>
/V /-' <br><br>
V <br><br>
- 6 - <br><br>
304509 <br><br>
thienyl-2-acetic acid optionally substituted on the thienyl ring. Such thienyl-2-acetic acids are used particularly in the synthesis of antibiotics, especially cephalosporins. The esters of formula (II) are thus <br><br>
5 available in large quantities at economical prices. <br><br>
The esters can readily be prepared from the corresponding acids by the usual esterification methods. <br><br>
Thus, the present compounds can be prepared in 3 <br><br>
stages from areadily accessible starting material, the <br><br>
10 ester of formula (II). <br><br>
R represents a lower alkyl radical, i.e. an alkyl radical of 1 to 4 carbon atoms, namely methyl, ethyl, <br><br>
propyl, isopropyl, butyl, isobutyl, secondary butyl or tert-butyl. R.^ Rg can independently represent <br><br>
15 one of these alkyl radicals or equally a halogen atom, <br><br>
namely fluorine, chlorine, bromine or iodine. <br><br>
Alk^ and Alk£ likewise can take any of the lower alkyl values listed above for R. <br><br>
The esters of formula (II) can be prepared by the <br><br>
20 usual methods from the corresponding acids which are described for example in United States Patent Specification i>Jo: 4180510 and its corresponding British Specification!No: 1573882. The reaction of the alkyl carbonate with the ester of formula (II) can be carried out in the presence of a strong base such as an alkali metal alcoholate, <br><br>
25 preferably sodium ethylate prepared in situ by the addition of sodium to anhydrous ethanol. Sodium or potassium tert-butylate can be used. It is also poasitele f(^' o Vi hSs^ n <br><br>
2 04 5 <br><br>
- 7 - <br><br>
to use a different strong base such as sodium hydride or another alkali metal hydride. This reaction can equally be carried out as a phase transfer reaction under the usual conditions. <br><br>
5 The reaction of the alkyl carbonate with the ester of formula (II) can be conducted in a reaction medium constituted by the alcohol when using an alkali metal alcoholate as the strong base. It is equally possible to proceed in the presence of another solvent, 10 for example toluene which can be used also to expel excess alcohol present in the medium. <br><br>
The proportions of the different materials can be varied according to the methods known to those skilled in the art. For example the quantity of sodium can vary 15 between 1 and 1.5 equivalents in relation to the ester of formula (II) when using sodium alcoholate as the base. The temperature and reaction time can likewise be varied. The length of reaction can vary for example from about 2 to 8 hours. The temperature can vary for example from 20 90 to 135° approximately (reflux of;, toluene or xylene). Finally, the carbonate of formula (Alk^^CO^ can be used in variable proportions. <br><br>
The malonate of formula (III) in which R^, R2 and Rg each represent a hydrogen atom and Alk^ and Alk2 25 each represent an ethyl radical is described with its process for preparation in J.A.C.S. 68, 1934 (1946). <br><br>
The conversion of the malonate of formula (III) <br><br>
- 8 - <br><br>
204509 <br><br>
into the alkylmalonate of formula (IV) is carried out in the presence of a strong base which can be as described above. The procedure is preferably the same as described above concerning sodium ethylate prepared in situ. The 5 process is preferably carried out in the presence of another solvent such as toluene. It is equally possible to proceed using a phase transfer reaction. <br><br>
The alkylating agent used to alkylate the malonate of formula (III) to the alkylmalonate of formula (IV) can 10 be considered as being of formula RX where R is as defined above and X is a group which functions so as to permit the alkylation. Alkylating agents are well known. The alkylating agent RX can be for example an alkyl halide such as the chloride, bromide, or iodide. The alkylating agent 15 can equally be an alkyl sulphate of formula (R)2S04 (X then represents half an S04). <br><br>
As previously, one can use varied conditions of temperature, reaction time and quantities of reagents. For example, one can use 1 to 1.5 moles of the alkylating 20 agent RX per mole of the malonate of formula (III). The reaction time can vary for example from 30 minutes to 3 hours. The temperature is preferably between 50 and 100°C, especially between 50 and 80°C. <br><br>
In a preferred embodiment, the alkylation is carried 25 out in the presence of sodium ethylate after eliminating the ethanol by means of a solvent such as toluene in which the alkylation is to be carried out. ,v-;' ; ■ <br><br>
i; <br><br>
- 9 - <br><br>
2 04 5 <br><br>
The conversion of the alkylmalonate of formula (IV) into the-2-thiophene acetic acid compound of formula (I) can be carried out by treatment with an alkaline base to obtain a salt of the desired acid compound, and 5 then with an acid to produce the desired acid compound. The first phase can be carried out either in water or in a mixture of water and water-miscible solvent. The solvent used is preferably a lower alcohol such as methanol ethanol or isopropanol. Sodium or potassium hydroxide 10 is preferably used as the alkaline base. <br><br>
The temperature is preferably between 20°C and the reflux temperature, especially between 50°C and the reflux temperature. The reaction time is preferably between 2 hours and 15 hours. <br><br>
15 The final acidification is preferably carried out with concentrated hydrochloric acid. The reaction is preferably carried out with the addition of an organic solvent such as toluene; the process is usually carried out at a temperature between the ambient temperature and 20 the reflux temperature of the solvent. <br><br>
Preferably, , R2 and R^ each represents a hydrogen atom, so that the compound is of formula (I1): <br><br>
- 10 - <br><br>
2 045 0 9 <br><br>
In that event, the corresponding ester of formula (II) is a thienyl acetic acid ester of formula (II1): <br><br>
) <br><br>
ch5-c0« Alk x <br><br>
2 2 2 (u») <br><br>
in which Alk2 is as defined above. <br><br>
Preferably, R represents a methyl or ethyl radical, 5 especially a methyl radical. <br><br>
Preferably, the present 2-thiophene acetic acid compound of formula (I) is produced in the 3 stages described, starting with the ester of formula (II), converting this into the malonate of formula (III), 10 alkylating this to the alkylmalonate of formula (IV), and converting this to the compound of formula (I). The sequence of the final 2 stages, however, the alkylation of the malonate of formula (III) to the alkylmalonate of formula (IV) and the conversion of this alkylmalonate to 15 the compound of formula (I), is particularly significant. Especially preferred is this sequence of the last 2 stages wherein R^, R2 and R^ each represents a hydrogen atom. <br><br>
A preferred embodiment is the 3 stage process described above .starting from ethyl carbonate and an ester <br><br>
- ii - 204509 <br><br>
of formula (II) in which Alk2 represents an ethyl radical. <br><br>
In the process of the invention, the strong base is preferably sodium ethylate. The alkylating agent is preferably an alkyl sulphate, especially methyl sulphate. <br><br>
Especially preferred is carrying out the present process in the following way to produce a-methyl 2-thiophene acetic acid: The process comprises reacting ethyl carbonate in the presence of sodium ethylate with ethyl thienyl-2-acetate to produce ethyl thienyl-2-malonate, which is reacted with methyl sulphate to produce ethyl thienyl-2-methyl malonate, which is reacted with sodium hydroxide and then hydrochloric acid to produce the a-methyl 2-thiophene acetic acid. <br><br>
The alkylmalonate of formula (IV) is a new compound and the invention provides it per se and its production by alkylating in the presence of a strong base the malonate of formula (III). It is preferred that in the alkylmalonate of formula (IV) , R2 and each represent a hydrogen atom. The most preferred alkylmalonate is ethyl thienyl-2-methyl malonate, and this is preferably used to produce a-methyl 2-thiophene acetic acid. <br><br>
The 2-thiophene acetic acid compound prepared in the present way can be employed as an intermediate in the preparation of a pharmaceutical. <br><br>
The invention is illustrated by the following Examples. <br><br>
204 5 <br><br>
- 12 - <br><br>
EXAMPLE 1: (X-rmethyl 2-thiophene acetic acid Stage A: ethyl thienyl-2-malonate <br><br>
225 cc of absolute ethanol and 16.5 g of sodium were mixed under nitrogen. Ethanol reflux was maintained 5 until the sodium had dissolved, and the solution was then concentrated to dryness under reduced pressure in order to eliminate the excess ethanol. 150 cc of ethyl carbonate were introduced onto the sodium ethylate at 100°C while the temperature was maintained between 90 and 95°C and then, 10 in 10 minutes, 100 g of ethyl thienyl-2-acetate and 100 cc of toluene were added. The temperature was brought to 105°C and in about 2 hours 120 cc of the toluene-ethanol--ethyl carbonate mixture were distilled off. The temperature was maintained at 105°C for a further 2 15 hours and then cooled down to 20°C, whereupon the resultant mixture was poured into 600 cc of iced water containing 80 cc of pure 22°Be hydrochloric acid. After decanting, the aqueous phase was re-extracted with toluene and the combined toluene extracts were washed with water. 20 The toluene solution was concentrated under reduced pressure. The expected crude product was obtained and this was distilled under a pressure of 2 mm of mercury. <br><br>
134.4 g of the expected product was obtained. <br><br>
Boiling point under 2 mm of mercury = 118-120°C. 25 Stage B: ethyl thienyl-2-methyl malonate <br><br>
10.45 g of sodium were introduced under nitrogen into 160 cc of absolute ethanol. Reflux was maintained <br><br>
204509 <br><br>
- 13 - <br><br>
for 45 minutes and 60 cc of ethanol were distilled off. 300 cc of toluene were added. The mixture was heated to reflux with continuous stirring and the ethanol was distilled off at constant volume by the addition of 5 toluene. 250 cc of toluene were added and about 250 cc of the ethanol-toluene mixture were recovered. <br><br>
The mixture was cooled down to 20°C, and 100 g of ethyl thienyl-2-malonate and 200 cc of toluene were added. Stirring was continued for 20 minutes. 150 cc 10 of the toluene-ethanol mixture were distilled off under reduced pressure, and then 100 cc of toluene were introduced under nitrogen. The mixture was heated to <br><br>
♦ <br><br>
70°C, and 60.9 g of dimethyl sulphate were added in 30 minutes. Thfe temperature was maintained at 80°C for 15 45 minutes and. then reduced to 20-25°C, when 200 cc of demineralised water were added. After 15 minutes stirring, the mixture was decanted, and . the toluene phase washed with 100 cc of water containing 5% 22°Be hydrochloric acid and then 4 times with 100 cc of demineralised water. 20 450 cc of toluene were distilled off under reduced pressure and the concentrate was left at 70°c under a presssure of 15-20 mm of mercury for one hour, yielding 105 g of the expected product. <br><br>
Stage C: oC-methyl 2-thiophene acetic acid. <br><br>
25 100 g of ethyl thienyl-2-methyl malonate and 200 cc of ethanol were added to a solution of 62.6 g of sodium hydroxide in 400 cc of dimineralised water. The resultant <br><br>
- 14 - <br><br>
20450 <br><br>
mixture was brought to 50°C over 4 hours, and then 300 cc of an ethanol-water mixture were distilled off under reduced pressure whilst maintaining the temperature below 50°C. The mixture was placed under nitrogen and 200 cc of 5 toluene and 140 cc of 22°Be hydrochloric acid were added in succession. The mixture was brought to reflux over 1 hour 30 minutes and then cooled to 20°C. After decanting, the toluene phase was washed several times with 50 cc of water and concentrated under reduced 10 pressure by distilling off 180 cc of toluene. The solvent was removed from the concentrate at 70°C for one hour under a pressure of 15-20 mm of mercury. 58.8 g of the expected product was obtained. <br><br>
EXAMPLE 2: thienyl-2-butyric acid 15 Stage A: ethyl thienyl-2-ethyl malonate <br><br>
12.54 g of sodium were introduced into 192 cc of absolute ethanol. Reflux was maintained for 45 minutes, and then 72 cc of ethanol were distilled off. 360 cc of toluene were added. The mixture was heated to reflux 20 to distill off the ethanol at constant volume by the addition of toluene. 300 cc of toluene were thus added and the same volume of toluene-ethanol mixture were recovered. The reaction mixture was cooled to 20°C and 120 g of ethyl thienyl-2-malonate and 240 cc of toluene 25 were added. After stirring for 20 minutes, 180 cc of toluene-ethanol mixture were distilled off under reduced presssure and 120 cc toluene were introduced under nitrogen. <br><br>
- 15 - <br><br>
2 045 0 9 <br><br>
The mixture was heated to 75°C, and 99.3 g of diethyl sulphate were then added over 30 minutes. The mixture was brought to reflux over one hour and then cooled to 20-25°C, and 240 cc of demineralised water were added. After 5 stirring for 15 minutes and decanting, the toluene phase was washed with 120 cc of demineralised water containing 5% 22°Be hydrochloric acid and then 4 times with 120 cc of water. The toluene phase was concentrated under reduced pressure after drying over sodium sulphate. The 10 solvent was removed from the concentrate under a pressure : of 15-20 mm of mercury at 70°C for one hour. 145.6 g of the expected product was obtained. <br><br>
This product was purified by distillation under a pressure of 0.5 mm of mercury. 113 g of the distilling 15 product was recovered at a temperature of 95-120°C. <br><br>
Stage B: thienyl-2-butyric acid <br><br>
A mixture of 62.6 g of sodium hyroxide in 400 cc of demineralised water were stirred under nitrogen until totally dissolved, after which 105.4 g of ethyl thienyl-2-20 -ethyl malonate and then 200 cc of ethanol were added. The resultant mixture was brought to 50°C over 4 hours and then 300 cc of ethanol-water mixture were distilled off under a pressure of 20 mm mercury at a temperature of about 50°C. 200 cc of toluene followed by 140 cc of 22°Be hydrochloric 25 acid were then introduced under nitrogen. The mixture was brought to reflux over 1 hour 30 minutes, cooled to 20°C and decanted. The aqueous phase was extracted with 50 cc of toluene and the toluene phase was washed several times <br><br></p>
</div>
Claims (20)
1. Process for the preparation of a 2-thiophene acetic acid compound of formula (I):<br><br> (I)<br><br> in which<br><br> R represents an alkyl radical of 1 to 4 carbon 5 atoms; and<br><br> R^, R2 and R^ are the same or different and each represents a hydrogen atom, an alkyl radical of'1 to 4 carbon atoms or a halogen atom;<br><br> which process comprises decarbalkoxylating an 10 alkylmalonate of formula (IV):<br><br> - 18 -<br><br> 2 04 5<br><br> in which R, R1, R2 and R3 are as defined above and Alk^ and Alk^ are the same or different and each represents an alkyl radical of 1 to 4 carbon atoms.<br><br>
2. Process according to claim 1 wherein the<br><br> 5 alkylmalonate of formula (IV) is prepared by alkylating in the presence of a strong base a malonate of formula (III):<br><br> C02AIkl<br><br> C02<br><br> (III)<br><br> in which R^, R2> R^, Alk.^ and Alk2 are as defined in claim 1.<br><br> 10
3. Process according to claim 2 wherein the malonate of formula (III) is prepared by reacting an alkyl carbonate of formula<br><br> (Alk1)2C03<br><br> in which Alk-^ is as defined in claim 2, in the presence 15 of a strong base with an ester of formula (II):<br><br> - 19 -<br><br> in which , R2, R^ and Alk2 are as defined in claim 2.<br><br>
4. Process according to claim 2 or 3 wherein the strong base is sodium ethylate.<br><br>
5. Process according to any one of claims 2-4<br><br> 5 wherein the malonate of formula (III) is alkylated with an alkyl sulphate of formula in which R is as defined in claim 1.<br><br>
6. Process according to any one of the preceding 10 claims wherein R-^ , R2 and R^ each represents a hydrogen atom.<br><br>
7. Process according to claim 6 wherein R represents a methyl radical.<br><br>
8. Process according to claim 6 wherein R represents<br><br> - 20 -<br><br> an ethyl radical.<br><br>
9. Process according to any one of the preceding claims wherein Alk-^ and Alk2 each represents an ethyl radical.<br><br> 5
10. Process for the preparation of 04-methyl 2-thiophene acetic acid, which process comprises reacting ethyl carbonate in the presence of sodium ethylate with ethyl thienyl-2-acetate to produce ethyl thienyl-2-malonate,<br><br> which is reacted with methyl sulphate to produce ethyl 10 thienyl-2-methyl malonate, which is reacted with sodium hydroxide and then hydrochloric acid to produce the 0L -methyl 2-thiophene acetic acid.<br><br>
11. Process according to any one of the preceding claims performed substantially as described herein. 15
12. Process according to any one of claims 1-10<br><br> performed substantially as described herein in Example 1 or in Example 2.<br><br>
13. A 2-thiophene acetic acid compound as defined in claim 1 when prepared by a process claimed in any one of<br><br> 20 the preceding claims.<br><br>
14. An alkylmalonate as defined in claim 1.<br><br>
15. An alkylmalonate according to claim 14 wherein , R2 and R3 each represents a hydrogen atom.<br><br>
16. Ethyl thienyl-2-methylmalonate.<br><br> 25
17. A process for preparing an alkylmalonate claimed in any one of claims 14-16, which process comprises alkylating in the presence of a strong base a malonate of<br><br> £04509<br><br> - 21 -<br><br> formula (III) as defined in claim 2.<br><br>
18. A process according to claim 17 performed substantially as described herein.<br><br>
19. A process according to claim 17 performed substantially as described herein in Example 1 or in Example 2.<br><br>
20. An alkylmalonate claimed in any one of claims 14-16 when prepared by a process claimed in any one of claims 17-19.<br><br> </p> </div>
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8220271A FR2537137B1 (en) | 1982-12-03 | 1982-12-03 | PROCESS FOR THE PREPARATION OF ACETIC 2-THIOPHENE ACID DERIVATIVES AND INTERMEDIATE PRODUCTS NECESSARY FOR THEIR PREPARATION |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ204509A true NZ204509A (en) | 1986-02-21 |
Family
ID=9279757
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ204509A NZ204509A (en) | 1982-12-03 | 1983-06-09 | 2-thiophene acetic acid derivates and their preparation |
Country Status (22)
Country | Link |
---|---|
JP (1) | JPS59106482A (en) |
KR (1) | KR900005681B1 (en) |
AT (1) | AT392784B (en) |
AU (1) | AU556803B2 (en) |
BE (1) | BE896439A (en) |
CA (1) | CA1201441A (en) |
CH (2) | CH655722A5 (en) |
DE (1) | DE3314029A1 (en) |
DK (2) | DK160427C (en) |
ES (1) | ES8401957A1 (en) |
FI (1) | FI83646C (en) |
FR (1) | FR2537137B1 (en) |
GB (1) | GB2132607B (en) |
HU (1) | HU192136B (en) |
IE (1) | IE55075B1 (en) |
IT (1) | IT1174757B (en) |
LU (1) | LU84748A1 (en) |
NL (1) | NL8301692A (en) |
NZ (1) | NZ204509A (en) |
PT (1) | PT76534B (en) |
SE (2) | SE453992B (en) |
ZA (1) | ZA832698B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0338494B1 (en) * | 1988-04-22 | 1996-01-10 | Byk Gulden Lomberg Chemische Fabrik GmbH | 3-Anilino-2-hydroxycarbonyl-4-thiophen-acetic acids |
IT1276738B1 (en) * | 1995-06-16 | 1997-11-03 | Erregierre Spa | PROCESS FOR THE PREPARATION OF DERIVATIVES OF -METHYL-2- THIOPHENEACETIC ACID |
DE102004008807A1 (en) | 2004-02-20 | 2005-09-08 | Bayer Cropscience Ag | pyrazolopyrimidine |
CN113896709B (en) * | 2021-11-22 | 2023-02-28 | 南京一苇医药科技有限公司 | Synthetic method of benzothiophene-3-acetic acid |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1055804A (en) * | 1949-10-01 | 1954-02-22 | Warner Hudnut | Improvements in processes for preparing anti-spasmodic compounds |
IE33054B1 (en) * | 1968-04-16 | 1974-03-06 | Ici Ltd | Heterocyclic compounds |
FR2260575A1 (en) * | 1974-02-11 | 1975-09-05 | Innothera Lab Sa | Cyclohexyl 3-thienyl acetic acid prodn - from methyl 3-thienylacetate through diethyl cyclohexyl 3-thienyl malonate as starting material for basic esters as drugs |
GB2003570B (en) * | 1977-06-08 | 1982-01-20 | Imi Opella Ltd | Stop valve |
FR2421897A1 (en) * | 1978-04-04 | 1979-11-02 | Labaz | Alpha substd. 3-thienyl:acetamide derivs. - useful as hypnotic, anticonvulsant and tranquillising agents |
-
1982
- 1982-12-03 FR FR8220271A patent/FR2537137B1/en not_active Expired
-
1983
- 1983-03-28 DK DK139983A patent/DK160427C/en not_active IP Right Cessation
- 1983-03-30 SE SE8301785A patent/SE453992B/en not_active IP Right Cessation
- 1983-03-31 FI FI831115A patent/FI83646C/en not_active IP Right Cessation
- 1983-04-05 ES ES521230A patent/ES8401957A1/en not_active Expired
- 1983-04-11 PT PT76534A patent/PT76534B/en not_active IP Right Cessation
- 1983-04-12 BE BE0/210536A patent/BE896439A/en unknown
- 1983-04-12 CH CH1967/83A patent/CH655722A5/en not_active IP Right Cessation
- 1983-04-12 CH CH4155/85A patent/CH659817A5/en not_active IP Right Cessation
- 1983-04-14 LU LU84748A patent/LU84748A1/en unknown
- 1983-04-14 HU HU831308A patent/HU192136B/en not_active IP Right Cessation
- 1983-04-15 AU AU13574/83A patent/AU556803B2/en not_active Ceased
- 1983-04-18 ZA ZA832698A patent/ZA832698B/en unknown
- 1983-04-18 DE DE19833314029 patent/DE3314029A1/en active Granted
- 1983-04-23 KR KR1019830001729A patent/KR900005681B1/en not_active IP Right Cessation
- 1983-05-04 IT IT48215/83A patent/IT1174757B/en active
- 1983-05-09 GB GB08312701A patent/GB2132607B/en not_active Expired
- 1983-05-10 IE IE1075/83A patent/IE55075B1/en not_active IP Right Cessation
- 1983-05-11 NL NL8301692A patent/NL8301692A/en active Search and Examination
- 1983-05-20 JP JP58087835A patent/JPS59106482A/en active Granted
- 1983-06-09 NZ NZ204509A patent/NZ204509A/en unknown
- 1983-07-28 CA CA000433421A patent/CA1201441A/en not_active Expired
- 1983-08-08 AT AT2866/83A patent/AT392784B/en not_active IP Right Cessation
-
1987
- 1987-09-09 SE SE8703494A patent/SE457724B/en not_active IP Right Cessation
-
1990
- 1990-06-06 DK DK138490A patent/DK164550C/en not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6515143B2 (en) | Method for producing ortho-alkylated benzoic acid derivatives | |
NZ204509A (en) | 2-thiophene acetic acid derivates and their preparation | |
KR20040026627A (en) | New process for the industrial synthesis of the methyl diester of 5-amino-3-carboxymethyl-4-cyano-2-thiophenecarboxylic acid, and application to the synthesis of bivalent salts of ranelic acid and their hydrates | |
JPS62161740A (en) | Production of phenylpropionic acid derivative | |
US4219659A (en) | Process for the preparation of thiophene derivatives and thiophene derivatives obtained therethrough | |
JP2000509384A (en) | Method for producing fluorine compound from corresponding amine | |
CA2233617A1 (en) | Process for the preparation of 4-methylenepiperidine | |
TW458975B (en) | Method for preparing benzothiophenecarboxylic acid amide derivatives | |
US3056775A (en) | Process for the production of new | |
US4186137A (en) | Process for preparing 3-thienyl-acetate derivatives | |
CA1327806C (en) | Thiophen compounds and their preparation | |
US6355836B1 (en) | Process for the preparation of cis 5-fluoro-2-methyl-1[p-(methylthio)benzyliden]-inden-3-acetic acid | |
AU611164B2 (en) | Novel thiophen compounds and their preparation | |
JPH10265433A (en) | Production of phenylpropionic acid derivative | |
Arutyunyan et al. | New Synthesis of 2-Acetonyl-4-alkoxymethylbutanolide | |
KR900006558B1 (en) | Process for preparing derivatives of alpha-hydroxy 2-thiophene acetic acid | |
JPS5896065A (en) | Manufacture of pyrrol-2-acetic acid ester | |
US3314974A (en) | Thienyl-1-naphthalene acetic acids and related compounds | |
AU760420B2 (en) | Synthesis of tetraalkylcyclopentadienes | |
EP0037271A1 (en) | Indole derivatives and process for preparing the same | |
IE47624B1 (en) | Process for the preparation of thiazolidin-4-one-acetic acid derivatives | |
JPS6137779A (en) | Manufacture of 5,6_dihydro_2h_thiopyran_3_ carboxyaldehyde | |
JP2002241337A (en) | Method of producing 6-methyl-4,6-heptadiene-2-one and 3,7-dimethyl-1,5,7-octatriene-3-ol | |
NO753414L (en) | ||
WO2001017930A1 (en) | Symmetric bis-indenyl ligands and process for their preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ASS | Change of ownership |
Owner name: AVENTIS PHARMA S.A., FR Free format text: OLD OWNER(S): HOECHST MARION ROUSSEL |